Business Business News Press Release

Lincoln Pharmaceuticals Ltd reports 57.85% rise in the Standalone Net Profit at ₹ 23.74 crore in Q2 FY23

Mr . Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd Highlights:- ·         Total Income from operation in Q2 FY23 at ₹ 146.30 crore, up 12.5% from ₹ 130.00 crore in Q1 FY23; ·         During the year, company got an approval from WHO-GMP for Tablet Capsule, dry-powder Suspension products at Cephalosporin plant. ·         Approved dividend of ₹ […]